Expression of vascular endothelial growth factor-C in primary cutaneous melanoma predicts sentinel lymph node positivity

Journal of Cutaneous Pathology

Volumn 39, Issue 9, 2012, Pages 826-834

  Cianfarani, Francesca ^a   Mastroeni, Simona ^a   Odorisio, Teresa ^a   Passarelli, Francesca ^a   Cattani, Caterina ^a   Mannooranparampil, Thomas J ^a   Fortes, Cristina ^a   Failla, Cristina M ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

immunohistochemistry; lymphangiogenesis; melanoma; tumor marker; VEGF C

Indexed keywords

CCR7 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR7; TUMOR MARKER; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; RECEPTORS, CCR7; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84865359623     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2012.01955.x     Document Type: Article

References (35)

1. Balch CM, Gershenwald JE, Soong S, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199.
2. Gimotty PA, Bothyl J, Soong S, DuPont G,. A population-based validation of the American Joint Committee on cancer melanoma staging system. J Clin Oncol 2005; 23: 8065.
3. Gimotty PA, Elder DE, Fraker DL, et al. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 2007; 25: 1129.
4. Bernard K, Litman E, Fitzpatrick JL, et al. Functional proteomic analysis of melanoma progression. Cancer Res 2003; 63: 6716.
5. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000; 406: 536.
6. Hood BL, Grahovac J, Flint MS, et al. Proteomic analysis of laser microdissected melanoma cells from skin organ cultures. J Proteome Res 2010; 9: 3656.
7. Winnepenninckx V, Lazar V, Michiels S, et al. Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 2006; 98: 472.
8. Gould Rothberg BE, Rimm DL,. Biomarkers: the useful and the not so useful-an assessment of molecular prognostic markers for cutaneous melanoma. J Invest Dermatol 2010; 130: 1971.
9. Schramm S-J, Mann GJ,. Melanoma Prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies. Mol Cancer Ther 2011; 10: 1520.
10. Nathanson SD,. Insights into the mechanisms of lymph node metastasis. Cancer 2003; 98: 413.
11. Korpelainen E, Alitalo K,. Signaling angiogenesis and lymphangiogenesis. Curr Opin Cell Biol 1998; 10: 159.
12. Karpanen T, Egeblad M, Karkkainen MJ, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001; 61: 1786.
13. Mandriota SJ, Jussila L, Jeltsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J 2001; 20: 672.
14. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by vascular endothelial growth factor-C promotes breast cancer metastasis. Nat Med 2001; 7: 192.
15. Zhang D, Li B, Shi J, et al. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Cancer Res 2010; 70: 2495.
16. He Y, Karpanen T, Alitalo K,. Role of lymphangiogenic factors in tumor metastasis. Biochem Biophys Acta 2004; 1654: 3.
17. Schietroma C, Cianfarani F, Lacal P, et al. Vascular endothelial growth factor -C expression correlates with lymph node localization of human melanoma metastases. Cancer 2003; 98: 789.
18. Liu B, Ma J, Wang X, et al. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma. Anat Rec 2008; 291: 1227.
19. Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002; 296: 1883.
20. Dadras SS, Paul T, Bertoncin J, et al. Tumor lymphangiogenesis. Am J Pathol 2003; 162: 1951.
21. Massi D, Puig S, Franchi A, et al. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol 2006; 59: 166.
22. Xu X, Gimotty PA, DuPont G, et al. Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis. Hum Pathol 2008; 39: 901.
23. Wobser M, Siedel C, Schrama D, Brocker EB, Becker JC, Vetter-Kauczok CS,. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma. Arch Dermatol Res 2006; 297: 352.
24. Straume O, Jackson DG, Akslen LA,. Independent prognostic impact of lymphatic vessel density and presence of low grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9: 250.
25. Yan C, Zhu Z-G, Yu Y-Y, et al. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. World J Gastroenterol 2004; 10: 783.
26. Wiley H, Gonzalez E, Maki W, Wu M, Hwang S,. Expression of CC chemokine receptor 7 and regional lymph node metastases of B16 murine melanoma. J Natl Cancer Inst 2001; 93: 1638.
27. Orecchia A, Scarponi C, Di Felice F, et al Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells PLoS One 2011; 6: e24307.
28. Banerji S, Ni J, Wang S, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789.
29. Breiteneder-Geleff S, Matsui K, Soleiman A, et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 1997; 151: 1141.
30. Boone B, Blokx W, De Bacquer D, Lambert J, Ruiter D, Brochez L,. The role of VEGF-C staining in predicting regional metastasis in melanoma. Virchows Arch 2008; 453: 257.
31. Goydos JS, Gorski DH,. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma. Clin Cancer Res 2003; 9: 5962.
32. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994.
33. Lu W, Schroit AJ,. Vascularization of melanoma by mobilization and remodeling of preexisting latent vessels to patency. Cancer Res 2005; 65: 913.
34. Ben-Baruch A,. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 2008; 25: 345.
35. Murakami T, Cardones AR, Hwang ST,. Chemokine receptors and melanoma metastasis. J Dermatol Sci 2004; 36: 71.